Novartis AG (ETR:NOT)

Market Cap	202.63B
Revenue (ttm)	46.99B
Net Income (ttm)	11.63B
Shares Out	n/a
EPS (ttm)	5.83
PE Ratio	17.43
Forward PE	14.40
Dividend	3.50 (3.36%)
Ex-Dividend Date	Mar 11, 2025

Volume	n/a
Average Volume	n/a
Open	103.46
Previous Close	103.48
Day's Range	103.46 - 104.70
52-Week Range	67.21 - 104.70
Beta	n/a
RSI	58.44
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Other
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: NOT

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD